Gavi, the Vaccine Alliance

06.24.2025

Gavi, the Vaccine Alliance: 25 years in 25 moments

 2023: Gavi reaches a billion children

In 2023, Gavi reached another milestone: more than 1 billion children vaccinated through routine programmes since the organisation was founded in 2000, with more than 18.8 million deaths averted as a result. By preventing illness and deaths, vaccines were estimated to have saved countries more than US$ 250 billion over the same period.

 2023: Gavi-supported countries break vaccine investment records

Gavi’s model is designed to encourage sustainability and sovereignty for countries, with governments paying more towards their vaccine programmes as their wealth increases. In 2023, Gavi's partner countries set a new record for co-financing, contributing US$ 200 million in one year for the first time.

 2024: Gavi supports the world’s first malaria vaccine introduction

On 22 January 2024, Cameroon made history by launching the world’s first routine malaria vaccination programme, with Gavi support. By the end of 2024, some 17 African countries were offering malaria vaccines through their routine childhood immunisation programmes, with more than 12 million vaccine doses delivered to these countries.

 2024: African vaccine manufacturing gets a boost

The COVID-19 pandemic highlighted the risks of relying too heavily on vaccine imports from other countries, with many countries in Africa having to wait longer for vaccines to become available because of a lack of local manufacturing capacity. In June 2024, Gavi launched a financing instrument called the African Vaccine Manufacturing Accelerator (AVMA), which will make up to US$ 1.2 billion available over ten years to accelerate the expansion of commercially viable vaccine manufacturing in Africa.

 2024: Gavi goes solar

As Gavi reaches its 25th birthday, it faces evolving challenges – including the worsening impact of climate change, which continues to increase the burden of disease in some of the world’s most vulnerable communities. Backed by Gavi funding, the Health Facility Solar Electrification (HFSE) initiative was launched in October 2024, with the goal of building climate-resilient health systems, while also boosting vaccine storage capacity. It will equip more than 1,000 health facilities across Ethiopia, Pakistan, Uganda and Zambia with solar panels to power essential cold chain equipment and other medical devices.

 2024: Four new vaccines join the Gavi portfolio

When Gavi started, it provided support for vaccines against six infectious diseases. By 2022 that number had grown to 19, and in June 2024, Gavi added preventive Ebola, routine multivalent meningitis, human rabies and hepatitis B birth dose to its portfolio of supported vaccines.